Clinical Trial Update: SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating surgery with or without darolutamide in high-risk and/or locally advanced prostate cancer. The study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nubeqa (darolutamide)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING